Jacques Zaneveld’s Post

🌐 DeepTech Ventures Summit 2024 by Technoport SA🌐 At the inaugural #DeepTechVentures Summit, Luxembourg’s innovation ecosystem, supported by LIST, among other institutes, showcased its capacity to transform research into #marketready solutions. With strong government support, Luxembourg is cementing its position as a #deeptech hub. 💡 LIST CEO ad interim Dirk Fransaer highlighted the importance of focusing on national research priorities while fostering global collaboration to deliver innovative, applicable solutions. Meet our spinoff companies and discover our high TRL solutions at DeepTech Ventures Demo Day on 20 September including👇 🛰 WASDI - a cloud-based environment for creating, using, and sharing Earth observation-based applications. ⚗ invitrolize - a leader in #invitro testing with its flagship technology, ALIsens®, the only in vitro alveolar model capable of obtaining OECD certification (Arno Gutleb, Sabina Burlă). 💉 ElectroPep - a pioneering #protein screening technology, showcased its innovation in peptide #microarrays, which can provide critical insights into peptide-protein interactions in under a week (Cesar Pascual García) 🏢 TwiSCO - a web application designed to optimize #construction #logistics using Semantic #DigitalTwin Technology and Lean Construction methodology (Fabrice Berroir) 🔬 NANOSENS - a suite of molecular sensing technologies (Sivashankar Krishnamoorthy) Find out more https://lnkd.in/dfcKPhbA

Collaborative Innovation Gone are the days of scientists toiling away in solo to produce world-changing innovations. In todays world, networked approaches are fueling creativity. Whether collaborating: - cross-functionally - across internal teams - partnering with customers, - external startups, - and research institutions, New collaborative innovation frameworks are proving critical for sustaining progress within Global LifeSciences. #avantorsetscienceinmotion

Are you an entrepreneur or researcher looking to transform your groundbreaking biotech ideas into reality? The journey from concept to market can be overwhelming, especially without the right resources and support. Many startups struggle to find suitable lab facilities that foster innovation and collaboration while providing the necessary infrastructure to execute their projects effectively. Don’t let your innovative ideas stay on the drawing board! Kickstart your biotech innovation journey with CUBIO—visit our website to schedule a tour of our facilities and discover how we can help you turn your ideas into reality. The future of biotech begins here!

Science Creates start-ups raise £33M this year to pursue deep tech ambitions 🥼🪙 Deep tech start-ups are gaining traction this year and Science Creates, which provides vital early stage funding, said its members collectively raised over £33 million in the first half of this year. The venture capital arm of the organisation highlighted this was more than double (at £14.4 million) the figure for its community-wide fundraising figure at the same time in 2021. And despite the challenging economic landscape, more broadly, equity investment in UK deep tech has soared from £174 million to more than £5 billion in the last ten years with Bristol continuing to claim an increasing chunk of regional and national deep tech companies. Continue reading... https://lnkd.in/efw3SiwT Delta.g, EnsiliTech, FOLIUM Science, Isomab Ltd, Kelpi, KETS Quantum Security, LettUs Grow, WASE #science #technologi #innovation #finance #growth #businessnews #businessintelligence

Powerhouses of European Innovation: Life Sciences Incubators This Thursday, we look forward to publishing our latest research on a vital aspect of the European life sciences ecosystem: incubators. These engines of innovation provide the flexible spaces, specialised equipment, and essential support services necessary to foster ingenuity. Drawing on a diverse sample of 20 incubators from various European cities, our research captures the unique characteristics and contributions of each incubator type, including: - Big vs. Small - New vs. Old - Single Sector vs. Multi-Sector - Private vs. Public Life sciences incubators are more than just buildings; they're dynamic environments where science meets business, and where ideas turn into reality. Key ingredients in their success include flexible physical spaces and adaptable lease/licence models, which provide startups with the agility they need to thrive. Furthermore, the resilient investment returns generated by these incubators have attracted some of the world's largest institutional investors. Maurizio Grilli Matthew Hopkinson Monika Sosnowska, PhD, FCCA, ATT Mark Charlton Potsdam Science Park DeepLabs NovaUCD BioLabs Innovation District Copenhagen Cosymbio Roeland Buckinx Toğrul Gönden #LifeSciences #Innovation #Research #Incubators #RealEstate #Europe

Check out Labiotech.eu’s latest article! Discover everything you need to know about stealth mode biotech startups in the new Labiotech article, “Stealth Mode Biotech Startups: Everything You Need to Know.” In this feature, Natalie Dolphin, our Managing Director, Investor Relations at HLTH Communications, shares her insights on the strategic advantages of operating in stealth mode, from safeguarding intellectual property to refining innovations away from the public eye. 📖 In the article, Natalie explains: “Operating in stealth mode offers biotech startups several strategic advantages, particularly in protecting intellectual property (IP) and allowing focused development away from the prying eyes of competitors.” If you’re curious about how stealth mode can help shape a biotech company’s success and protect its innovations, this is a must-read! 👉 Check out the full article to learn how stealth mode can pave the way for groundbreaking developments and market success. Link in comments!

Is #deeptech a good investment thesis? Well that would be like asking the question, is a app based business a good or bad investment 🚀 - The only answer is it depends. I recently had a coffee ☕ meeting with PreSeed Ventures regarding their new #deeptechfond which will be looking for #earlystage investments. I have on some of my previous posts shared #spinout (university #startup with #ipr based on #research) generally performs better than the counter parts, based on data from DTU - Technical University of Denmark and DTU Skylab . Which means that knowledge based deeptech score higher on most #kpi (expect speed to market) So are these cases #venture cases? My clear answer is #yes in both my conversations with Dr. ir. Ana Koller and Jacob Graves Beck. And here are my reflections on why. DTU is a relatively small university on a global scale with explicit emphasis on #entrepreneurship that is less than a decade old set in motion by Anders Overgaard Bjarklev, Marianne Thellersen and Mikkel Sørensen. In spite of this short experience and size, we still produce #unicorns like 3Shape and NKT Photonics. And some companies that could have reached these heights earlier with better capital infrastructure. But we also have the next generation of companies claiming the growth 📈 hills to become unicorns who will it be? Eupry Reshape Biotech NIL Technology Norlase MASH Makes So statistically, then there is a higher frequency of unicorns among deeptech and they have a higher likelihood of reaching higher valuations with reduced risks other than time 🤔 This leaves me with the question, are we or have we become a unicorn factory or is it in our DNA 🧬 to fight the odds?

Cost Efficiency for Biotech Startups: Lease vs. Shared Lab Space Thinking of leasing or subleasing lab space? The upfront costs can be staggering. At Labshares, we offer a smarter, more affordable alternative with our shared laboratory model. Here’s the comparison: Traditional Lease/Sublease: •Upfront costs: $500K–$1M+ •Long-term commitments •Expensive lab buildouts and equipment purchases Shared Lab Space at Labshares: •Immediate access to fully equipped labs •Flexible, low upfront costs •All-inclusive pricing (utilities, maintenance, and equipment included) By choosing LabShares, early-stage biotech startups can focus their budgets on innovation and R&D, not overhead. 🔗 Ready to scale smarter and faster? Visit us: labshares.com #LabShares #BiotechStartups #CostEfficiency #SharedLabSpace #LifeScienceInnovation #BostonBiotech

Scientific research drives progress and innovation, often sparking the possibility to make a tangible impact on society. Yet, transitioning discoveries into viable ventures isn't without its challenges. From navigating the complexities of market applications to securing funding and engaging with potential investors, the journey from bench to bedside demands strategic navigation. Issues like identifying core applications, breaking through traditional norms, and securing resources are common. This is where Orchestra Life Sciences steps in. With our expertise in market analysis, strategic planning, and engineering solutions, we guide emerging biotech ventures to navigate these obstacles with confidence. By leveraging our insights and network, we help start-ups refine their focus, attract investors, and showcase their potential. #Biotech #ScientificEntrepreneurship #OLSExpertise

𝗬𝗼𝘂 𝗵𝗮𝘃𝗲 𝗼𝗻𝗹𝘆 𝘁𝘄𝗼 𝗺𝗼𝗿𝗲 𝘄𝗲𝗲𝗸𝘀 𝘁𝗼 𝗮𝗽𝗽𝗹𝘆 𝘁𝗼 𝗙𝗿𝗼𝗺 𝗟𝗮𝗯 𝘁𝗼 𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲! That being said, we would like to remind you again why participating in our idea competition is a great opportunity: 👀 View your research from another angle 🤝 Make connections with like-minded scientists who consider taking their research to market as well as industry experts and capital specialists 🧑🔬 Make major progress like teams which participated in the last two years, ChemInnovation, Octo Germany, Alteva Technologies, MechSyn and ChitoNExt, teams which have successfully secured funding to found their companies. Participate by filling out the form on our website, link in the comments. 🚀 #startup #futurefounders #chemistry #biotech